# ERO1B

## Overview
ERO1B, or endoplasmic reticulum oxidoreductase 1 beta, is a gene that encodes a thiol oxidoreductase enzyme involved in oxidative protein folding within the endoplasmic reticulum of mammalian cells. The protein encoded by ERO1B is characterized by its flavin adenine dinucleotide (FAD)-binding domain, which is essential for its function in facilitating the formation of disulfide bonds in nascent polypeptides. This process is crucial for proper protein folding and maintaining cellular homeostasis. ERO1B is particularly significant in pancreatic β-cells, where it plays a vital role in insulin biosynthesis and secretion, contributing to glucose homeostasis. The enzyme's activity is regulated by disulfide bond combinations, providing a potent oxidizing capacity, although it is less tightly regulated than its paralog ERO1α. Despite its role in generating reactive oxygen species, ERO1B's function is not detrimental when knocked down in normal cells, indicating the presence of redundant pathways for disulfide bond formation (Shergalis2020Role; Grenko2024Singlecell).

## Structure
ERO1B (endoplasmic reticulum oxidoreductase 1 beta) is a protein characterized by its involvement in oxidative protein folding within the endoplasmic reticulum. The protein contains a flavin adenine dinucleotide (FAD)-binding domain, which is essential for its oxidoreductase activity. This domain plays a critical role in facilitating the transfer of electrons during the formation of disulfide bonds, which are integral to the protein's function in oxidative folding.

The molecular structure of ERO1B includes disulfide bonds that are crucial for electron transfer processes. These bonds contribute to the protein's stability and functionality within the endoplasmic reticulum. The presence of these disulfide bonds suggests a complex tertiary structure that supports its enzymatic activity.

ERO1B may also undergo post-translational modifications, such as glycosylation, which can influence its stability, localization, and function. These modifications are common in proteins that operate within the endoplasmic reticulum, where they can affect protein folding and interactions.

While specific details on the secondary and quaternary structures of ERO1B are not provided, the presence of the FAD-binding domain and disulfide bonds indicates a highly specialized structure adapted for its role in oxidative protein folding.

## Function
ERO1B, or endoplasmic reticulum oxidoreductase 1 beta, is a thiol oxidoreductase enzyme that plays a critical role in the formation of disulfide bonds in nascent polypeptides within the endoplasmic reticulum (ER) of mammalian cells. This process is essential for proper protein folding, which is crucial for maintaining cellular homeostasis and function (Shergalis2020Role). ERO1B facilitates electron transfer from protein disulfide isomerase (PDI) to oxygen, producing hydrogen peroxide (H2O2) as a byproduct. This activity helps maintain the oxidizing environment of the ER, which is necessary for the correct folding of proteins (Shergalis2020Role).

In healthy human cells, ERO1B is particularly important in pancreatic β-cells, where it is involved in insulin biosynthesis and secretion. It is highly expressed in the pancreas, underscoring its role in glucose homeostasis (Shergalis2020Role; Grenko2024Singlecell). ERO1B's activity is regulated by disulfide bond combinations, providing a powerful oxidizing capacity when needed, although it is less tightly regulated than its paralog ERO1α (Shergalis2020Role). Despite its significant role in generating reactive oxygen species (ROS) in the ER, ERO1B's function is not detrimental when knocked down in normal cells, suggesting the presence of redundant pathways for disulfide bond formation (Shergalis2020Role).

## Clinical Significance
Alterations in the expression of the ERO1B gene have been implicated in several diseases, particularly diabetes and certain cancers. In the context of diabetes, ERO1B plays a crucial role in insulin biogenesis and glucose homeostasis. ERO1B deficiency in mice is associated with impaired insulin folding and production, leading to a diabetic phenotype characterized by ER stress-induced cell death and delayed proinsulin folding, which hampers insulin secretion (Shergalis2020Role). In diabetic mouse models, ERO1B expression is lower in the islets, and its expression decreases with age, suggesting a link between ERO1B deficiency and the pathogenesis of type 2 diabetes (Shergalis2020Role).

In cancer, ERO1B expression is notably lower than ERO1A in most cancers, but it shows the highest median expression in liver hepatocellular carcinoma and pancreatic adenocarcinoma, indicating potential relevance in these cancers (Shergalis2020Role). The specific tissue expression of ERO1B may contribute to its differential expression in cancerous tissues (Shergalis2020Role). Despite its role in cancer, no significant associations have been found between ERO1B expression and reduced survival or disease progression, unlike ERO1A, which is more prominently linked to cancer outcomes (Shergalis2020Role).

## Interactions
ERO1B, an endoplasmic reticulum oxidoreductase, plays a crucial role in the formation of disulfide bonds in proteins within the endoplasmic reticulum. It interacts primarily with protein disulfide isomerase (PDI) to facilitate oxidative protein folding. This interaction is essential for transferring disulfide bonds, with ERO1B using flavin adenine dinucleotide (FAD) as a cofactor to reduce molecular oxygen, generating hydrogen peroxide in the process (Benham2013Ero1–PDI; Shergalis2020Role).

ERO1B is expressed predominantly in the pancreas and stomach, where it plays a significant role in insulin biogenesis and glucose homeostasis. Its interaction with PDI is less tightly regulated compared to its paralog ERO1α, allowing ERO1B to have a more potent oxidizing capacity (Shergalis2020Role). The interaction between ERO1B and PDI is crucial for maintaining redox homeostasis and ensuring proper protein maturation within the endoplasmic reticulum. While specific details on ERO1B's interactions with other proteins or nucleic acids are limited, it is suggested that ERO1B may form complexes with other ER-resident proteins, contributing to its function in oxidative protein folding (Benham2013Ero1–PDI).


## References


[1. (Benham2013Ero1–PDI) Adam M. Benham, Marcel van Lith, Roberto Sitia, and Ineke Braakman. Ero1–pdi interactions, the response to redox flux and the implications for disulfide bond formation in the mammalian endoplasmic reticulum. Philosophical Transactions of the Royal Society B: Biological Sciences, 368(1617):20110403, May 2013. URL: http://dx.doi.org/10.1098/rstb.2011.0403, doi:10.1098/rstb.2011.0403. This article has 61 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1098/rstb.2011.0403)

[2. (Shergalis2020Role) Andrea G. Shergalis, Shuai Hu, Armand Bankhead, and Nouri Neamati. Role of the ero1-pdi interaction in oxidative protein folding and disease. Pharmacology &amp; Therapeutics, 210:107525, June 2020. URL: http://dx.doi.org/10.1016/j.pharmthera.2020.107525, doi:10.1016/j.pharmthera.2020.107525. This article has 86 citations.](https://doi.org/10.1016/j.pharmthera.2020.107525)

[3. (Grenko2024Singlecell) Caleb M. Grenko, Henry J. Taylor, Lori L. Bonnycastle, Dongxiang Xue, Brian N. Lee, Zoe Weiss, Tingfen Yan, Amy J. Swift, Erin C. Mansell, Angela Lee, Catherine C. Robertson, Narisu Narisu, Michael R. Erdos, Shuibing Chen, Francis S. Collins, and D. Leland Taylor. Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 h. Diabetologia, 67(10):2246–2259, July 2024. URL: http://dx.doi.org/10.1007/s00125-024-06214-4, doi:10.1007/s00125-024-06214-4. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-024-06214-4)